Acquisition brings together Personalis’ MRD technology with Tempus’ commercial scale, multimodal data and AI platform to advance cancer monitoring, deepen insights and accelerate growth Expands Tempus’ reach across the...read more
Category - Liquid biopsy
From Experimentation to Execution: How 2025 Reset the Trajectory of Healthcare and What 2026 Will Demand
TL;DR 2025 shifted healthcare from experimentation to execution AI moved from tools to infrastructure 2026 will reward disciplined execution over vision Why this matters for precision medicine + generative AI This...read more
2023 Watch List: Top 10 Precision Medicine Technologies and Issues
CADTH routinely identifies new and emerging technologies that are likely to have a significant and meaningful impact on Canada’s health care systems. CADTH’s annual watch lists specifically identify technologies that...read more
We Invite you to join enlightenbio’s Subject Matter Expert Network!
enlightenbio is a boutique consultancy providing product strategy and market intelligence to precision medicine industries. Our mission is to help our clients successfully develop, launch, and market exceptional...read more
